These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35395139)

  • 1. In vitro effects of thirty-eight cardiac drugs on human serum paraoxonase.
    Argan O; Cikrikci K; Uslu H; Gencer N
    Chem Biol Drug Des; 2022 Jul; 100(1):80-89. PubMed ID: 35395139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Some coumarins and benzoxazinones as potent paraoxonase 1 inhibitors.
    Karataş MO; Uslu H; Alıcı B; Gökçe B; Gencer N; Arslan O
    J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1386-91. PubMed ID: 26887799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant and antipsychotic drugs differentially affect PON1 enzyme activity.
    Avcikurt AS; Sinan S; Kockar F
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):245-9. PubMed ID: 24934243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of human serum paraoxonase-1 with some respiratory drugs.
    Gökçe B; Sarıoğlu N; Gençer N; Arslan O
    J Biochem Mol Toxicol; 2019 Dec; 33(12):e22407. PubMed ID: 31581362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel purification strategy for human PON1 and inhibition of the activity by cephalosporin and aminoglikozide derived antibiotics.
    Sinan S; Kockar F; Arslan O
    Biochimie; 2006 May; 88(5):565-74. PubMed ID: 16600468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of Potential Paraoxonase-I Inhibitors by Kinetic and Molecular Docking Studies: Chemotherapeutic Drugs.
    Türkeş C
    Protein Pept Lett; 2019; 26(6):392-402. PubMed ID: 30819074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of some antibiotics on paraoxonase from human serum in vitro and from mouse serum and liver in vivo.
    Sinan S; Kockar F; Gencer N; Yildirim H; Arslan O
    Biol Pharm Bull; 2006 Aug; 29(8):1559-63. PubMed ID: 16880604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some cardiovascular therapeutics inhibit paraoxonase 1 (PON1) from human serum.
    Işgör MM; Beydemir S
    Eur J Pharmacol; 2010 Oct; 645(1-3):135-42. PubMed ID: 20670621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of Holstein bull semen paraoxonase 1 (PON1) by hydrophobic interaction chromatography and investigation of its inhibition kinetics by heavy metals.
    Dedeoğlu N; Arslan M; Erzengin M
    Biol Trace Elem Res; 2014 Apr; 158(1):29-35. PubMed ID: 24563030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An alternative purification method for human serum paraoxonase 1 and its interaction with methidathion.
    Gençer N; Yavuz E
    Arch Physiol Biochem; 2017 Jul; 123(3):159-164. PubMed ID: 28276711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro inhibition effect of some dihydroxy coumarin compounds on purified human serum paraoxonase 1 (PON1).
    Erzengin M; Basaran I; Cakir U; Aybey A; Sinan S
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1540-8. PubMed ID: 22971832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotics Used in Patients after Surgery and Effects of Human Serum Paraoxonase-I (PON1) Enzyme Activity.
    Yılmaz A; Dilek E
    Protein Pept Lett; 2019; 26(3):215-220. PubMed ID: 30678610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some calcium-channel blockers: kinetic and
    Türkeş C; Demir Y; Beydemir Ş
    J Biomol Struct Dyn; 2022 Jan; 40(1):77-85. PubMed ID: 32783605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the inhibitory effects and molecular docking of some sulfonamides on human serum paraoxonase 1.
    Alim Z; Kilic D; Koksal Z; Beydemir S; Ozdemir H
    J Biochem Mol Toxicol; 2017 Oct; 31(10):. PubMed ID: 28665493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of bovine serum paraoxonase and its immobilization on Eupergit C 250 L by covalent attachment.
    Sayın M; Guler OO
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):69-74. PubMed ID: 24679050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation and in silico study of benzohydrazide derivatives as paraoxonase 1 inhibitors.
    Korkmaz IN; Türkeş C; Demir Y; Öztekin A; Özdemir H; Beydemir Ş
    J Biochem Mol Toxicol; 2022 Nov; 36(11):e23180. PubMed ID: 35916346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of Human Serum Paraoxonase-I with Antimycotic Drugs: In Vitro and In Silico Studies.
    Türkeş C; Beydemir Ş
    Appl Biochem Biotechnol; 2020 Jan; 190(1):252-269. PubMed ID: 31342307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of in vitro effect, molecular docking, and molecular dynamics simulations of some dihydropyridine-class calcium channel blockers on human serum paraoxonase 1 (hPON1) enzyme activity.
    Gökçe B; Muhammed MT
    Biotechnol Appl Biochem; 2023 Oct; 70(5):1707-1719. PubMed ID: 37071114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Some indazoles reduced the activity of human serum paraoxonase 1, an antioxidant enzyme:
    Alım Z; Kılıç D; Demir Y
    Arch Physiol Biochem; 2019 Dec; 125(5):387-395. PubMed ID: 29741961
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular Docking Studies and Inhibition Properties of Some Antineoplastic Agents against Paraoxonase-I.
    Demir Y; Türkeş C; Beydemir Ş
    Anticancer Agents Med Chem; 2020; 20(7):887-896. PubMed ID: 32067621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.